A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)

Clinical trial NCT05788926 · TERMINATED

Trial details

NCT number: NCT05788926
Sponsor: Transgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2023-04-05
Primary completion: 2025-06-23
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.